Article
dl-VSVG-LacZ, a vesicular stomatitis virus glycoprotein epitope-incorporated adenovirus, exhibits marked enhancement in gene transduction efficiency.
Human gene therapy - 20 Nov 2003
Yun Chae-Ok, Cho Eun-A, Song Jae-Jin, Kang Dae-Bong, Kim Eunhee, Sohn Joo-Hyuk, Kim Joo-Hang
Abstract excerpt
Recombinant adenovirus (Ad) has emerged as the vector system of choice in cancer gene therapy. Its full utility, however, has been limited because of the low efficiency of adenovirus-mediated gene transfer to cancer cells - the main reason being that cancer cells in general express inherently low levels of the coxsackie and adenovirus receptor (CAR) on their surface. Development of novel strategies to achieve...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
